In Vitro Toxicology Testing Market - Global Industry Analysis

In Vitro Toxicology Testing Market By Technology (Proteomics, Toxicogenomics, High-throughput Technologies, Transcriptomics, OMICS Technologies, Molecular Imaging Technologies, Metabolomics, Genomics, and Cell Culture Technology), By Product (Issue Culture Assays, Enzyme Toxicity Assays, Reagents & Labware, Cell-Based ELISA and Western Blots, Services, Bacterial Toxicity Assays, Assays Receptor Binding Assays, and Other Assays), By Industry (Oral Fluid Screening, Diagnostics, Chemical Industry, Hair Screening, Cosmetics & Household Products, Alcohol Screening, Pharmaceutical Industry, Food Industry, Urine Screening, and Other Diagnostics): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2028

Published Date: 24-May-2021 Category: Pharmaceutical Report Format : PDF Pages: 150 Report Code: ZMR-965 Status : Published

The global In Vitro Toxicology Testing market accounted for USD 16,266.6 Million in 2020 and is expected to reach USD 32,201.7 Million by 2028, growing at a CAGR of 9.4% from 2021 to 2028.

Description

Market Overview

The global In Vitro Toxicology Testing market accounted for USD 16,266.6 Million in 2020 and is expected to reach USD 32,201.7 Million by 2028, growing at a CAGR of 9.4% from 2021 to 2028.

The method of determining the potential for hazardous substances is known as in-vitro toxicity testing. It is also used to check for the presence of unusual toxic characteristics in useful substances like agricultural chemicals, therapeutic medications, and food additives. The development of 3D cell culture systems that mimic host physiology has allowed for safe in-vitro testing of new compounds, reducing the need for animal testing models. In-vitro toxicology and computational methods have gained in popularity because of this.

COVID-19 Impact Analysis

Health supplies and equipment are at risk of running out due to the rapid spread of COVID-19, which has resulted in the temporary closure of manufacturing sites in COVID-19-affected areas and travel restrictions that have hampered shipments.

The demand for in vitro toxicology technologies, especially diagnostic assays, and PCR, has increased in tandem with the demand for faster testing and research in the field. Various in vitro diagnostic kits, such as in vitro diagnostic assays and PCR testing panels, as well as medications, have been licenced by the FDA for emergency use in COVID -19 testing and diagnostics.

Growth Factors

New and promising innovations, as well as resistance to animal testing, are driving the growth of the in vitro toxicology testing industry.

The two growth factors of In Vitro Toxicology Testing market are Opposition to animal testing, Animal testing is a time-consuming process that comes at a high cost and poses significant safety risks to the animals involved. Using rodent and rabbit models increases the risk of zoonotic disease transmission. In-vitro toxicology and computational methods have gained in popularity because of this.

The second growth factor is Increasing pharmaceutical R&D activities, changing trends in the global healthcare markets have forced pharmaceutical and biotechnology companies to create products that provide tangible value rather than only incremental benefits. However, R&D practises are linked to a high risk of failure. Intensive R&D is carried out in the early stages of drug production to accomplish this. Increased R&D spending early in the drug development process is likely to boost the use of in vivo toxicology approaches before the drug enters the more costly clinical level.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Technology Segment Analysis

In 2019, cell culture technology dominated the market because it is an outstanding model for analysing toxic effects because it offers accurate samples and reproducible outcomes, allowing for early toxicity detection in the drug development phase. Furthermore, cell cultures are gradually replacing animal research, resulting in their widespread use. Due to the benefits, it provides, 3D cell culture models have gained a lot of popularity in recent years. It promotes tissue-specific activity, differentiation, and cell proliferation, for example.

OMICS technology, on the other hand, is expected to grow at the fastest rate during the forecast period because it provides personalised toxicology data, which provides better insights and reduces variability in the data obtained. OMICS technologies largely contribute to a deeper understanding of the toxicity of nano-sized materials such as metal, carbon, and metal oxide nanoparticles.

Industry Segment Analysis

In-vitro toxicology testing is most used in the pharmaceutical industry, owing to the high demand for biopharmaceuticals. The widespread use of toxicology testing in the pharmacokinetic study of new and genetically modified pharmaceutical products has resulted in an increase in the revenue of these toxicity testing assays. Furthermore, with many drug candidates in the pipeline, demand for in-vitro toxicology testing is expected to increase. These assays are primarily used in three areas of drug production to comply with evolving regulatory guidelines: ADME, safety pharmacology, and genotoxicity testing of drug candidates.

Regional Segment Analysis

The North America region is projected to grow at a CAGR of 6.5% over the forecast period.  North America, which includes the United States and Canada, dominated the in vivo toxicology market. The involvement of major players operating in the in vivo toxicology market in the United States, the biomedical research in the United States, and the preclinical activities by CROs and pharmaceutical companies in the area account for the region's large share. Technical advances and supportive government legislation have accelerated the creation of advanced, cost-effective testing for determining medication, device, chemical, and cosmetic protection in North America over the last few years.

Asia Pacific, since government organisations are increasingly focusing on promoting toxicology testing using in-vitro methods, the Asia Pacific region is expected to expand at the fastest pace. Furthermore, conducting clinical trials in Asian countries is less expensive than in Western countries, which is why many biopharmaceutical companies conduct their drug production in this field.

Key Market Players & Competitive Landscape

Few Market Players are Thermo Fisher Scientific Inc. (US), Covance Inc. (US), Bio-Rad Laboratories, Inc. (US), GE Healthcare Inc. (US), Eurofins Scientific SE (Luxembourg), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Catalent, Inc. (US), Cyprotex (UK), SGS S.A. (Switzerland), QIAGEN N.V. (German (US).

Participants in the market are working to boost in-silico simulation methods for toxicological profiling of various compounds by developing software solutions. Market players are also looking to extend their reach by entering new markets and partnering with smaller manufacturers who specialise in in-vitro testing.

The global In Vitro Toxicology Testing market is segmented as follows:

By Technology

  • Proteomics
  • Toxicogenomics
  • High-throughput Technologies
  • Transcriptomics
  • OMICS Technologies
  • Molecular Imaging Technologies
  • Metabolomics
  • Genomics
  • Cell Culture Technology

By Product

  • Issue Culture Assays
  • Enzyme Toxicity Assays
  • Reagents & Labware
  • Cell-Based ELISA
  • Western Blots
  • Services
  • Bacterial Toxicity Assays
  • Receptor Binding Assays
  • Other Assays

By Industry

  • Oral Fluid Screening
  • Diagnostics
  • Chemical Industry
  • Hair Screening
  • Cosmetics & Household Products
  • Alcohol Screening
  • Pharmaceutical Industry
  • Food Industry
  • Urine Screening
  • Other Diagnostics

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Technology
        • 2.1.1.2. Market Attractiveness Analysis, By Product
        • 2.1.1.3. Market Attractiveness Analysis, By Industry
        • 2.1.1.4. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global In Vitro Toxiculogy Testing Market, 2016 – 2028 (USD)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 In Vitro Toxiculogy Testing Market – Technology Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Technology, 2020 & 2028
    • 4.2. Proteomics
      • 4.2.1. Market Size and Forecast, By Region (USD)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Toxicogenomics
      • 4.3.1. Market Size and Forecast, By Region (USD)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.4. High-throughput Technulogies
      • 4.4.1. Market Size and Forecast, By Region (USD)
      • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.5. Transcriptomics
      • 4.5.1. Market Size and Forecast, By Region (USD)
      • 4.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.6. OMICS Technulogies
      • 4.6.1. Market Size and Forecast, By Region (USD)
      • 4.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.6.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.7. Mulecular Imaging Technulogies
      • 4.7.1. Market Size and Forecast, By Region (USD)
      • 4.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.7.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.8. Metabulomics
      • 4.8.1. Market Size and Forecast, By Region (USD)
      • 4.8.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.8.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.9. Genomics
      • 4.9.1. Market Size and Forecast, By Region (USD)
      • 4.9.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.9.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.10. Cell Culture Technology
      • 4.10.1. Market Size and Forecast, By Region (USD)
      • 4.10.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.10.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 In Vitro Toxiculogy Testing Market – Product Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By Product, 2020 & 2028
    • 5.2. Issue Culture Assays
      • 5.2.1. Market Size and Forecast, By Region (USD)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Enzyme Toxicity Assays
      • 5.3.1. Market Size and Forecast, By Region (USD)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Reagents & Labware
      • 5.4.1. Market Size and Forecast, By Region (USD)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.5. Cell-Based ELISA and Western Blots
      • 5.5.1. Market Size and Forecast, By Region (USD)
      • 5.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.6. Services
      • 5.6.1. Market Size and Forecast, By Region (USD)
      • 5.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.6.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.7. Bacterial Toxicity Assays
      • 5.7.1. Market Size and Forecast, By Region (USD)
      • 5.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.7.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.8. Receptor Binding Assays
      • 5.8.1. Market Size and Forecast, By Region (USD)
      • 5.8.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.8.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.9. Other Assays
      • 5.9.1. Market Size and Forecast, By Region (USD)
      • 5.9.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.9.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 6 In Vitro Toxiculogy Testing Market – Industry Segment Analysis
    • 6.1. Overview
      • 6.1.1. Market Revenue Share, By Industry, 2020 & 2028
    • 6.2. Oral Fluid Screening
      • 6.2.1. Market Size and Forecast, By Region (USD)
      • 6.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.3. Diagnostics
      • 6.3.1. Market Size and Forecast, By Region (USD)
      • 6.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.4. Chemical Industry
      • 6.4.1. Market Size and Forecast, By Region (USD)
      • 6.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.5. Hair Screening
      • 6.5.1. Market Size and Forecast, By Region (USD)
      • 6.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.6. Cosmetics & Househuld Products
      • 6.6.1. Market Size and Forecast, By Region (USD)
      • 6.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.6.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.7. Alcohul Screening
      • 6.7.1. Market Size and Forecast, By Region (USD)
      • 6.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.7.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.8. Pharmaceutical Industry
      • 6.8.1. Market Size and Forecast, By Region (USD)
      • 6.8.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.8.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.9. Food Industry
      • 6.9.1. Market Size and Forecast, By Region (USD)
      • 6.9.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.9.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.10. Other Diagnostics
      • 6.10.1. Market Size and Forecast, By Region (USD)
      • 6.10.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.10.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 7 In Vitro Toxiculogy Testing Market – Regional Analysis
    • 7.1. Overview
      • 7.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 7.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD)
    • 7.2. North America
      • 7.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD)
      • 7.2.2. North America Market Revenue, By Technology, 2016 – 2028
      • 7.2.3. North America Market Revenue, By Product, 2016 – 2028
      • 7.2.4. North America Market Revenue, By Industry, 2016 – 2028
      • 7.2.5. U.S.
        • 7.2.5.1. U.S. Market Revenue, By Technology, 2016 – 2028
        • 7.2.5.2. U.S. Market Revenue, By Product, 2016 – 2028
        • 7.2.5.3. U.S. Market Revenue, By Industry, 2016 – 2028
      • 7.2.6. Canada
        • 7.2.6.1. Canada Market Revenue, By Technology, 2016 – 2028
        • 7.2.6.2. Canada Market Revenue, By Product, 2016 – 2028
        • 7.2.6.3. Canada Market Revenue, By Industry, 2016 – 2028
      • 7.2.7. Mexico
        • 7.2.7.1. Mexico Market Revenue, By Technology, 2016 – 2028
        • 7.2.7.2. Mexico Market Revenue, By Product, 2016 – 2028
        • 7.2.7.3. Mexico Market Revenue, By Industry, 2016 – 2028
    • 7.3. Europe
      • 7.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD)
      • 7.3.2. Europe Market Revenue, By Technology, 2016 – 2028
      • 7.3.3. Europe Market Revenue, By Product, 2016 – 2028
      • 7.3.4. Europe Market Revenue, By Industry, 2016 – 2028
      • 7.3.5. Germany
        • 7.3.5.1. Germany Market Revenue, By Technology, 2016 – 2028
        • 7.3.5.2. Germany Market Revenue, By Product, 2016 – 2028
        • 7.3.5.3. Germany Market Revenue, By Industry, 2016 – 2028
      • 7.3.6. France
        • 7.3.6.1. France Market Revenue, By Technology, 2016 – 2028
        • 7.3.6.2. France Market Revenue, By Product, 2016 – 2028
        • 7.3.6.3. France Market Revenue, By Industry, 2016 – 2028
      • 7.3.7. U.K.
        • 7.3.7.1. U.K. Market Revenue, By Technology, 2016 – 2028
        • 7.3.7.2. U.K. Market Revenue, By Product, 2016 – 2028
        • 7.3.7.3. U.K. Market Revenue, By Industry, 2016 – 2028
      • 7.3.8. Italy
        • 7.3.8.1. Italy Market Revenue, By Technology, 2016 – 2028
        • 7.3.8.2. Italy Market Revenue, By Product, 2016 – 2028
        • 7.3.8.3. Italy Market Revenue, By Industry, 2016 – 2028
      • 7.3.9. Spain
        • 7.3.9.1. Spain Market Revenue, By Technology, 2016 – 2028
        • 7.3.9.2. Spain Market Revenue, By Product, 2016 – 2028
        • 7.3.9.3. Spain Market Revenue, By Industry, 2016 – 2028
      • 7.3.10. Rest of Europe
        • 7.3.10.1. Rest of Europe Market Revenue, By Technology, 2016 – 2028
        • 7.3.10.2. Rest of Europe Market Revenue, By Product, 2016 – 2028
        • 7.3.10.3. Rest of Europe Market Revenue, By Industry, 2016 – 2028
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD)
      • 7.4.2. Asia Pacific Market Revenue, By Technology, 2016 – 2028
      • 7.4.3. Asia Pacific Market Revenue, By Product, 2016 – 2028
      • 7.4.4. Asia Pacific Market Revenue, By Industry, 2016 – 2028
      • 7.4.5. China
        • 7.4.5.1. China Market Revenue, By Technology, 2016 – 2028
        • 7.4.5.2. China Market Revenue, By Product, 2016 – 2028
        • 7.4.5.3. China Market Revenue, By Industry, 2016 – 2028
      • 7.4.6. Japan
        • 7.4.6.1. Japan Market Revenue, By Technology, 2016 – 2028
        • 7.4.6.2. Japan Market Revenue, By Product, 2016 – 2028
        • 7.4.6.3. Japan Market Revenue, By Industry, 2016 – 2028
      • 7.4.7. India
        • 7.4.7.1. India Market Revenue, By Technology, 2016 – 2028
        • 7.4.7.2. India Market Revenue, By Product, 2016 – 2028
        • 7.4.7.3. India Market Revenue, By Industry, 2016 – 2028
      • 7.4.8. South Korea
        • 7.4.8.1. South Korea Market Revenue, By Technology, 2016 – 2028
        • 7.4.8.2. South Korea Market Revenue, By Product, 2016 – 2028
        • 7.4.8.3. South Korea Market Revenue, By Industry, 2016 – 2028
      • 7.4.9. South-East Asia
        • 7.4.9.1. South-East Asia Market Revenue, By Technology, 2016 – 2028
        • 7.4.9.2. South-East Asia Market Revenue, By Product, 2016 – 2028
        • 7.4.9.3. South-East Asia Market Revenue, By Industry, 2016 – 2028
      • 7.4.10. Rest of Asia Pacific
        • 7.4.10.1. Rest of Asia Pacific Market Revenue, By Technology, 2016 – 2028
        • 7.4.10.2. Rest of Asia Pacific Market Revenue, By Product, 2016 – 2028
        • 7.4.10.3. Rest of Asia Pacific Market Revenue, By Industry, 2016 – 2028
    • 7.5. Latin America
      • 7.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD)
      • 7.5.2. Latin America Market Revenue, By Technology, 2016 – 2028
      • 7.5.3. Latin America Market Revenue, By Product, 2016 – 2028
      • 7.5.4. Latin America Market Revenue, By Industry, 2016 – 2028
      • 7.5.5. Brazil
        • 7.5.5.1. Brazil Market Revenue, By Technology, 2016 – 2028
        • 7.5.5.2. Brazil Market Revenue, By Product, 2016 – 2028
        • 7.5.5.3. Brazil Market Revenue, By Industry, 2016 – 2028
      • 7.5.6. Argentina
        • 7.5.6.1. Argentina Market Revenue, By Technology, 2016 – 2028
        • 7.5.6.2. Argentina Market Revenue, By Product, 2016 – 2028
        • 7.5.6.3. Argentina Market Revenue, By Industry, 2016 – 2028
      • 7.5.7. Rest of Latin America
        • 7.5.7.1. Rest of Latin America Market Revenue, By Technology, 2016 – 2028
        • 7.5.7.2. Rest of Latin America Market Revenue, By Product, 2016 – 2028
        • 7.5.7.3. Rest of Latin America Market Revenue, By Industry, 2016 – 2028
    • 7.6. The Middle-East and Africa
      • 7.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD)
      • 7.6.2. The Middle-East and Africa Market Revenue, By Technology, 2016 – 2028
      • 7.6.3. The Middle-East and Africa Market Revenue, By Product, 2016 – 2028
      • 7.6.4. The Middle-East and Africa Market Revenue, By Industry, 2016 – 2028
      • 7.6.5. GCC Countries
        • 7.6.5.1. GCC Countries Market Revenue, By Technology, 2016 – 2028
        • 7.6.5.2. GCC Countries Market Revenue, By Product, 2016 – 2028
        • 7.6.5.3. GCC Countries Market Revenue, By Industry, 2016 – 2028
      • 7.6.6. South Africa
        • 7.6.6.1. South Africa Market Revenue, By Technology, 2016 – 2028
        • 7.6.6.2. South Africa Market Revenue, By Product, 2016 – 2028
        • 7.6.6.3. South Africa Market Revenue, By Industry, 2016 – 2028
      • 7.6.7. Rest of Middle-East Africa
        • 7.6.7.1. Rest of Middle-East Africa Market Revenue, By Technology, 2016 – 2028
        • 7.6.7.2. Rest of Middle-East Africa Market Revenue, By Product, 2016 – 2028
        • 7.6.7.3. Rest of Middle-East Africa Market Revenue, By Industry, 2016 – 2028
  • Chapter No. 8 In Vitro Toxiculogy Testing Market – Industry Analysis
    • 8.1. Introduction
    • 8.2. Market Drivers
      • 8.2.1. Driving Factor 1 Analysis
      • 8.2.2. Driving Factor 2 Analysis
    • 8.3. Market Restraints
      • 8.3.1. Restraining Factor Analysis
    • 8.4. Market Opportunities
      • 8.4.1. Market Opportunity Analysis
    • 8.5. Porter’s Five Forces Analysis
    • 8.6. PEST Analysis
    • 8.7. Regulatory Landscape
    • 8.8. Technology Landscape
    • 8.9. Regional Market Trends
      • 8.9.1. North America
      • 8.9.2. Europe
      • 8.9.3. Asia Pacific
      • 8.9.4. Latin America
      • 8.9.5. The Middle-East and Africa
    • 8.10. Pricing Analysis
    • 8.11. Value Chain Analysis
    • 8.12. Downstream Buyers
    • 8.13. Distributors/Traders List
  • Chapter No. 9 Competitive Landscape
    • 9.1. Company Market Share Analysis – 2019
      • 9.1.1. Global In Vitro Toxiculogy Testing Market: Company Market Share, 2019
      • 9.1.2. Global In Vitro Toxiculogy Testing Market, Company Market Revenue, 2016 – 2019 (USD)
      • 9.1.3. Global In Vitro Toxiculogy Testing Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 9.1.4. Global In Vitro Toxiculogy Testing Market: Radar Determinant Chart, 2019
    • 9.2. Strategic Developments
      • 9.2.1. Acquisitions & Mergers
      • 9.2.2. New Product Launch
      • 9.2.3. Regional Expansion
    • 9.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 10 Company Profiles
    • 10.1. Thermo Fisher Scientific Inc.
      • 10.1.1. Company Overview
      • 10.1.2. Key Executives
      • 10.1.3. Product Portfolio
      • 10.1.4. Financial Overview
      • 10.1.5. Operating Business Segments
      • 10.1.6. Business Performance
      • 10.1.7. Recent Developments
    • 10.2. Covance Inc.
    • 10.3. Bio-Rad Laboratories Inc.
    • 10.4. GE Healthcare Inc.
    • 10.5. Eurofins Scientific SE (Luxembourg)
    • 10.6. Merck KGaA (Germany)
    • 10.7. Charles River Laboratories International, Inc.
    • 10.8. Catalent, Inc.
    • 10.9. Cyprotex
    • 10.10. SGS S.A.
    • 10.11. QIAGEN N.V.
  • Chapter No. 11 Marketing Strategy Analysis
    • 11.1. Marketing Channel
    • 11.2. Direct Marketing
    • 11.3. Indirect Marketing
    • 11.4. Marketing Channel Development Trends
    • 11.5. Economic/Pulitical Environmental Change
  • Chapter No. 12 Research Methodology
    • 12.1. Research Methodology
    • 12.2. Phase I - Secondary Research
    • 12.3. Phase II - Data Modeling
      • 12.3.1. Company Share Analysis Model
      • 12.3.2. Revenue Based Modeling
    • 12.4. Phase III - Primary Research
    • 12.5. Research Limitations
      • 12.5.1. Assumptions

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Technology
FIG NO. 2. Market Attractiveness Analysis, By Product
FIG NO. 3. Market Attractiveness Analysis, By Industry
FIG NO. 4. Market Attractiveness Analysis, By Region
FIG NO. 5. Global In Vitro Toxicology Testing   Market Revenue, 2016 – 2028 (USD)
FIG NO. 6. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 7. Market Revenue Share, By Technology, 2020 & 2028
FIG NO. 8. Global In Vitro Toxicology Testing   Market for Proteomics, Revenue (USD) 2016 – 2028
FIG NO. 9. Comparative Revenue Analysis of In Vitro Toxicology Testing   Market for Proteomics, By Country, 2020 & 2028
FIG NO. 10. Global In Vitro Toxicology Testing   Market for Toxicogenomics, Revenue (USD) 2016 – 2028
FIG NO. 11. Comparative Revenue Analysis of In Vitro Toxicology Testing   Market for Toxicogenomics, By Country, 2020 & 2028
FIG NO. 12. Global In Vitro Toxicology Testing   Market for High-throughput Technologies, Revenue (USD) 2016 – 2028
FIG NO. 13. Comparative Revenue Analysis of In Vitro Toxicology Testing   Market for High-throughput Technologies, By Country, 2020 & 2028
FIG NO. 14. Global In Vitro Toxicology Testing   Market for Transcriptomics, Revenue (USD) 2016 – 2028
FIG NO. 15. Comparative Revenue Analysis of In Vitro Toxicology Testing   Market for Transcriptomics, By Country, 2020 & 2028
FIG NO. 16. Global In Vitro Toxicology Testing   Market for OMICS Technologies, Revenue (USD) 2016 – 2028
FIG NO. 17. Comparative Revenue Analysis of In Vitro Toxicology Testing   Market for OMICS Technologies, By Country, 2020 & 2028
FIG NO. 18. Global In Vitro Toxicology Testing   Market for Molecular Imaging Technologies, Revenue (USD) 2016 – 2028
FIG NO. 19. Comparative Revenue Analysis of In Vitro Toxicology Testing   Market for Molecular Imaging Technologies, By Country, 2020 & 2028
FIG NO. 20. Global In Vitro Toxicology Testing   Market for Metabolomics, Revenue (USD) 2016 – 2028
FIG NO. 21. Comparative Revenue Analysis of In Vitro Toxicology Testing   Market for Metabolomics, By Country, 2020 & 2028
FIG NO. 22. Global In Vitro Toxicology Testing   Market for Genomics, Revenue (USD) 2016 – 2028
FIG NO. 23. Comparative Revenue Analysis of In Vitro Toxicology Testing   Market for Genomics, By Country, 2020 & 2028
FIG NO. 24. Global In Vitro Toxicology Testing   Market for Cell Culture Technology, Revenue (USD) 2016 – 2028
FIG NO. 25. Comparative Revenue Analysis of In Vitro Toxicology Testing   Market for Cell Culture Technology, By Country, 2020 & 2028
FIG NO. 26. Market Revenue Share, By Product, 2020 & 2028
FIG NO. 27. Global In Vitro Toxicology Testing   Market for Issue Culture Assays, Revenue (USD) 2016 – 2028
FIG NO. 28. Comparative Revenue Analysis of In Vitro Toxicology Testing   Market for Issue Culture Assays, By Country, 2020 & 2028
FIG NO. 29. Global In Vitro Toxicology Testing   Market for Enzyme Toxicity Assays, Revenue (USD) 2016 – 2028
FIG NO. 30. Comparative Revenue Analysis of In Vitro Toxicology Testing   Market for Enzyme Toxicity Assays, By Country, 2020 & 2028
FIG NO. 31. Global In Vitro Toxicology Testing   Market for Reagents & Labware, Revenue (USD) 2016 – 2028
FIG NO. 32. Comparative Revenue Analysis of In Vitro Toxicology Testing   Market for Reagents & Labware, By Country, 2020 & 2028
FIG NO. 33. Global In Vitro Toxicology Testing   Market for Cell-Based ELISA and Western Blots, Revenue (USD) 2016 – 2028
FIG NO. 34. Comparative Revenue Analysis of In Vitro Toxicology Testing   Market for Cell-Based ELISA and Western Blots, By Country, 2020 & 2028
FIG NO. 35. Global In Vitro Toxicology Testing   Market for Services, Revenue (USD) 2016 – 2028
FIG NO. 36. Comparative Revenue Analysis of In Vitro Toxicology Testing   Market for Services, By Country, 2020 & 2028
FIG NO. 37. Global In Vitro Toxicology Testing   Market for Bacterial Toxicity Assays, Revenue (USD) 2016 – 2028
FIG NO. 38. Comparative Revenue Analysis of In Vitro Toxicology Testing   Market for Bacterial Toxicity Assays, By Country, 2020 & 2028
FIG NO. 39. Global In Vitro Toxicology Testing   Market for Receptor Binding Assays, Revenue (USD) 2016 – 2028
FIG NO. 40. Comparative Revenue Analysis of In Vitro Toxicology Testing   Market for Receptor Binding Assays, By Country, 2020 & 2028
FIG NO. 41. Global In Vitro Toxicology Testing   Market for Other Assays, Revenue (USD) 2016 – 2028
FIG NO. 42. Comparative Revenue Analysis of In Vitro Toxicology Testing   Market for Other Assays, By Country, 2020 & 2028
FIG NO. 43. Market Revenue Share, By Industry, 2020 & 2028
FIG NO. 44. Global In Vitro Toxicology Testing   Market for Oral Fluid Screening, Revenue (USD) 2016 – 2028
FIG NO. 45. Comparative Revenue Analysis of In Vitro Toxicology Testing   Market for Oral Fluid Screening, By Country, 2020 & 2028
FIG NO. 46. Global In Vitro Toxicology Testing   Market for Diagnostics, Revenue (USD) 2016 – 2028
FIG NO. 47. Comparative Revenue Analysis of In Vitro Toxicology Testing   Market for Diagnostics, By Country, 2020 & 2028
FIG NO. 48. Global In Vitro Toxicology Testing   Market for Chemical Industry, Revenue (USD) 2016 – 2028
FIG NO. 49. Comparative Revenue Analysis of In Vitro Toxicology Testing   Market for Chemical Industry, By Country, 2020 & 2028
FIG NO. 50. Global In Vitro Toxicology Testing   Market for Hair Screening, Revenue (USD) 2016 – 2028
FIG NO. 51. Comparative Revenue Analysis of In Vitro Toxicology Testing   Market for Hair Screening, By Country, 2020 & 2028
FIG NO. 52. Global In Vitro Toxicology Testing   Market for Cosmetics & Household Products, Revenue (USD) 2016 – 2028
FIG NO. 53. Comparative Revenue Analysis of In Vitro Toxicology Testing   Market for Cosmetics & Household Products, By Country, 2020 & 2028
FIG NO. 54. Global In Vitro Toxicology Testing   Market for Alcohol Screening, Revenue (USD) 2016 – 2028
FIG NO. 55. Comparative Revenue Analysis of In Vitro Toxicology Testing   Market for Alcohol Screening, By Country, 2020 & 2028
FIG NO. 56. Global In Vitro Toxicology Testing   Market for Pharmaceutical Industry, Revenue (USD) 2016 – 2028
FIG NO. 57. Comparative Revenue Analysis of In Vitro Toxicology Testing   Market for Pharmaceutical Industry, By Country, 2020 & 2028
FIG NO. 58. Global In Vitro Toxicology Testing   Market for Food Industry, Revenue (USD) 2016 – 2028
FIG NO. 59. Comparative Revenue Analysis of In Vitro Toxicology Testing   Market for Food Industry, By Country, 2020 & 2028
FIG NO. 60. Global In Vitro Toxicology Testing   Market for Other Diagnostics, Revenue (USD) 2016 – 2028
FIG NO. 61. Comparative Revenue Analysis of In Vitro Toxicology Testing   Market for Other Diagnostics, By Country, 2020 & 2028
FIG NO. 62. Global In Vitro Toxicology Testing   Market Revenue Share, By Region, 2020 & 2028
FIG NO. 63. North America In Vitro Toxicology Testing   Market Revenue, 2016 - 2028 (USD)
FIG NO. 64. Porter’s Five Forces Analysis for Global In Vitro Toxicology Testing   Market
FIG NO. 65. PEST Analysis for Global In Vitro Toxicology Testing   Market
FIG NO. 66. Pricing Analysis for Global In Vitro Toxicology Testing   Market
FIG NO. 67. Value Chain Analysis for Global In Vitro Toxicology Testing   Market
FIG NO. 68. Company Share Analysis, 2019
FIG NO. 69. Radar Determinant Chart, 2019
FIG NO. 70. Company Strategic Developments – Heat Map Analysis
FIG NO. 71. Thermo Fisher Scientific Inc. Business Segment Revenue Share, 2020 (%)
FIG NO. 72. Thermo Fisher Scientific Inc. Geographical Segment Revenue Share, 2020 (%)
FIG NO. 73. Market Channels
FIG NO. 74. Marketing Channel Development Trend
FIG NO. 75. Growth in World Gross Product, 2008-2018
FIG NO. 76. Research Methodology – Detailed View
FIG NO. 77. Research Methodology
 


List of Tables 

TABLE NO. 1. Global In Vitro Toxicology Testing   Market: Snapshot
TABLE NO. 2. Quarterly In Vitro Toxicology Testing   Market Revenue by Region, 2020
TABLE NO. 3. Quarterly In Vitro Toxicology Testing   Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD)
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD)
TABLE NO. 6. Global In Vitro Toxicology Testing   Market for Proteomics, by Region, 2016 – 2028 (USD)
TABLE NO. 7. Global In Vitro Toxicology Testing   Market for Toxicogenomics, by Region, 2016 – 2028 (USD)
TABLE NO. 8. Global In Vitro Toxicology Testing   Market for High-throughput Technologies, by Region, 2016 – 2028 (USD)
TABLE NO. 9. Global In Vitro Toxicology Testing   Market for Transcriptomics, by Region, 2016 – 2028 (USD)
TABLE NO. 10. Global In Vitro Toxicology Testing   Market for OMICS Technologies, by Region, 2016 – 2028 (USD)
TABLE NO. 11. Global In Vitro Toxicology Testing   Market for Molecular Imaging Technologies, by Region, 2016 – 2028 (USD)
TABLE NO. 12. Global In Vitro Toxicology Testing   Market for Metabolomics, by Region, 2016 – 2028 (USD)
TABLE NO. 13. Global In Vitro Toxicology Testing   Market for Genomics, by Region, 2016 – 2028 (USD)
TABLE NO. 14. Global In Vitro Toxicology Testing   Market for Cell Culture Technology, by Region, 2016 – 2028 (USD)
TABLE NO. 15. Global In Vitro Toxicology Testing   Market for Issue Culture Assays, by Region, 2016 – 2028 (USD)
TABLE NO. 16. Global In Vitro Toxicology Testing   Market for Enzyme Toxicity Assays, by Region, 2016 – 2028 (USD)
TABLE NO. 17. Global In Vitro Toxicology Testing   Market for Reagents & Labware, by Region, 2016 – 2028 (USD)
TABLE NO. 18. Global In Vitro Toxicology Testing   Market for Cell-Based ELISA and Western Blots, by Region, 2016 – 2028 (USD)
TABLE NO. 19. Global In Vitro Toxicology Testing   Market for Services, by Region, 2016 – 2028 (USD)
TABLE NO. 20. Global In Vitro Toxicology Testing   Market for Bacterial Toxicity Assays, by Region, 2016 – 2028 (USD)
TABLE NO. 21. Global In Vitro Toxicology Testing   Market for Receptor Binding Assays, by Region, 2016 – 2028 (USD)
TABLE NO. 22. Global In Vitro Toxicology Testing   Market for Other Assays, by Region, 2016 – 2028 (USD)
TABLE NO. 23. Global In Vitro Toxicology Testing   Market for Oral Fluid Screening, by Region, 2016 – 2028 (USD)
TABLE NO. 24. Global In Vitro Toxicology Testing   Market for Diagnostics, by Region, 2016 – 2028 (USD)
TABLE NO. 25. Global In Vitro Toxicology Testing   Market for Chemical Industry, by Region, 2016 – 2028 (USD)
TABLE NO. 26. Global In Vitro Toxicology Testing   Market for Hair Screening, by Region, 2016 – 2028 (USD)
TABLE NO. 27. Global In Vitro Toxicology Testing   Market for Cosmetics & Household Products, by Region, 2016 – 2028 (USD)
TABLE NO. 28. Global In Vitro Toxicology Testing   Market for Alcohol Screening, by Region, 2016 – 2028 (USD)
TABLE NO. 29. Global In Vitro Toxicology Testing   Market for Pharmaceutical Industry, by Region, 2016 – 2028 (USD)
TABLE NO. 30. Global In Vitro Toxicology Testing   Market for Food Industry, by Region, 2016 – 2028 (USD)
TABLE NO. 31. Global In Vitro Toxicology Testing   Market for Other Diagnostics, by Region, 2016 – 2028 (USD)
TABLE NO. 32. Global In Vitro Toxicology Testing   Market Revenue, By Region, 2016 – 2028 (USD)
TABLE NO. 33. North America In Vitro Toxicology Testing   Market Revenue, By Country, 2016 – 2028 (USD)
TABLE NO. 34. North America In Vitro Toxicology Testing   Market Revenue, By Technology, 2016 – 2028 (USD)
TABLE NO. 35. North America In Vitro Toxicology Testing   Market Revenue, By Product, 2016 – 2028 (USD)
TABLE NO. 36. North America In Vitro Toxicology Testing   Market Revenue, By Industry, 2016 – 2028 (USD)
TABLE NO. 37. U.S. In Vitro Toxicology Testing   Market Revenue, By Technology, 2016 – 2028 (USD)
TABLE NO. 38. U.S. In Vitro Toxicology Testing   Market Revenue, By Product, 2016 – 2028 (USD)
TABLE NO. 39. U.S. In Vitro Toxicology Testing   Market Revenue, By Industry, 2016 – 2028 (USD)
TABLE NO. 40. Canada In Vitro Toxicology Testing   Market Revenue, By Technology, 2016 – 2028 (USD)
TABLE NO. 41. Canada In Vitro Toxicology Testing   Market Revenue, By Product, 2016 – 2028 (USD)
TABLE NO. 42. Canada In Vitro Toxicology Testing   Market Revenue, By Industry, 2016 – 2028 (USD)
TABLE NO. 43. Mexico In Vitro Toxicology Testing   Market Revenue, By Technology, 2016 – 2028 (USD)
TABLE NO. 44. Mexico In Vitro Toxicology Testing   Market Revenue, By Product, 2016 – 2028 (USD)
TABLE NO. 45. Mexico In Vitro Toxicology Testing   Market Revenue, By Industry, 2016 – 2028 (USD)
TABLE NO. 46. Drivers for the In Vitro Toxicology Testing   Market: Impact Analysis
TABLE NO. 47. Restraints for the In Vitro Toxicology Testing   Market: Impact Analysis
TABLE NO. 48. Major Buyers of In Vitro Toxicology Testing
TABLE NO. 49. Distributors/Traders List of In Vitro Toxicology Testing
TABLE NO. 50. Global In Vitro Toxicology Testing   Market, Company Market Revenue, 2016 – 2019 (USD)
TABLE NO. 51. Global In Vitro Toxicology Testing   Market, Company Y-o-Y Growth, 2017 – 2019 (USD)
 

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

The global In Vitro Toxicology Testing market was valued at USD 16,266.6 Million in 2020.

The global In Vitro Toxicology Testing market is expected to reach USD 32,201.7 Million by 2028, growing at a CAGR of 9.4% between 2021 to 2028.

Some of the key factors driving the global In Vitro Toxicology Testing market growth are government support for toxicology studies, resistance to animal testing, and emerging advances in toxicology research.

North American market is expected to dominate the global in vitro toxicology testing market, and this trend is expected to continue during the evaluation era. The demand for in vitro toxicology research in North America is the most promising, with a strong CAGR expected over the forecast period.

Some of the major companies operating in the In Vitro Toxicology Testing market are Thermo Fisher Scientific Inc. (US), Covance Inc. (US), Bio-Rad Laboratories, Inc. (US), GE Healthcare Inc. (US), Eurofins Scientific SE (Luxembourg), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Catalent, Inc. (US), Cyprotex (UK), SGS S.A. (Switzerland), QIAGEN N.V. (German (US).

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed